Report Overview:
Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country.
The Global Gastrointestinal OTC Drugs Market Size was estimated at USD 6200.43 million in 2023 and is projected to reach USD 8500.91 million by 2029, exhibiting a CAGR of 5.40% during the forecast period.
This report provides a deep insight into the global Gastrointestinal OTC Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter?s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastrointestinal OTC Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastrointestinal OTC Drugs market in any manner.
Global Gastrointestinal OTC Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
Market Segmentation (by Type)
Laxatives
Anti-Flatulents
H2-Antaginists
Anti-Diarrheals
PPIs
Anti-Emetics
Other
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Gastrointestinal OTC Drugs Market
? Overview of the regional outlook of the Gastrointestinal OTC Drugs Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal OTC Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Gastrointestinal OTC Drugs
1.2 Key Market Segments
1.2.1 Gastrointestinal OTC Drugs Segment by Type
1.2.2 Gastrointestinal OTC Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Gastrointestinal OTC Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Gastrointestinal OTC Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gastrointestinal OTC Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Gastrointestinal OTC Drugs Market Competitive Landscape
3.1 Global Gastrointestinal OTC Drugs Sales by Manufacturers (2019-2024)
3.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gastrointestinal OTC Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gastrointestinal OTC Drugs Sales Sites, Area Served, Product Type
3.6 Gastrointestinal OTC Drugs Market Competitive Situation and Trends
3.6.1 Gastrointestinal OTC Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gastrointestinal OTC Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Gastrointestinal OTC Drugs Industry Chain Analysis
4.1 Gastrointestinal OTC Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Gastrointestinal OTC Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Gastrointestinal OTC Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal OTC Drugs Sales Market Share by Type (2019-2024)
6.3 Global Gastrointestinal OTC Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Gastrointestinal OTC Drugs Price by Type (2019-2024)
7 Gastrointestinal OTC Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal OTC Drugs Market Sales by Application (2019-2024)
7.3 Global Gastrointestinal OTC Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Gastrointestinal OTC Drugs Sales Growth Rate by Application (2019-2024)
8 Gastrointestinal OTC Drugs Market Segmentation by Region
8.1 Global Gastrointestinal OTC Drugs Sales by Region
8.1.1 Global Gastrointestinal OTC Drugs Sales by Region
8.1.2 Global Gastrointestinal OTC Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Gastrointestinal OTC Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gastrointestinal OTC Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gastrointestinal OTC Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 GlaxoSmithKline
9.1.1 GlaxoSmithKline Gastrointestinal OTC Drugs Basic Information
9.1.2 GlaxoSmithKline Gastrointestinal OTC Drugs Product Overview
9.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Product Market Performance
9.1.4 GlaxoSmithKline Business Overview
9.1.5 GlaxoSmithKline Gastrointestinal OTC Drugs SWOT Analysis
9.1.6 GlaxoSmithKline Recent Developments
9.2 Pfizer
9.2.1 Pfizer Gastrointestinal OTC Drugs Basic Information
9.2.2 Pfizer Gastrointestinal OTC Drugs Product Overview
9.2.3 Pfizer Gastrointestinal OTC Drugs Product Market Performance
9.2.4 Pfizer Business Overview
9.2.5 Pfizer Gastrointestinal OTC Drugs SWOT Analysis
9.2.6 Pfizer Recent Developments
9.3 Johnson and Johnson
9.3.1 Johnson and Johnson Gastrointestinal OTC Drugs Basic Information
9.3.2 Johnson and Johnson Gastrointestinal OTC Drugs Product Overview
9.3.3 Johnson and Johnson Gastrointestinal OTC Drugs Product Market Performance
9.3.4 Johnson and Johnson Gastrointestinal OTC Drugs SWOT Analysis
9.3.5 Johnson and Johnson Business Overview
9.3.6 Johnson and Johnson Recent Developments
9.4 Bayer
9.4.1 Bayer Gastrointestinal OTC Drugs Basic Information
9.4.2 Bayer Gastrointestinal OTC Drugs Product Overview
9.4.3 Bayer Gastrointestinal OTC Drugs Product Market Performance
9.4.4 Bayer Business Overview
9.4.5 Bayer Recent Developments
9.5 Procter and Gamble
9.5.1 Procter and Gamble Gastrointestinal OTC Drugs Basic Information
9.5.2 Procter and Gamble Gastrointestinal OTC Drugs Product Overview
9.5.3 Procter and Gamble Gastrointestinal OTC Drugs Product Market Performance
9.5.4 Procter and Gamble Business Overview
9.5.5 Procter and Gamble Recent Developments
9.6 Perrigo
9.6.1 Perrigo Gastrointestinal OTC Drugs Basic Information
9.6.2 Perrigo Gastrointestinal OTC Drugs Product Overview
9.6.3 Perrigo Gastrointestinal OTC Drugs Product Market Performance
9.6.4 Perrigo Business Overview
9.6.5 Perrigo Recent Developments
9.7 Abbott
9.7.1 Abbott Gastrointestinal OTC Drugs Basic Information
9.7.2 Abbott Gastrointestinal OTC Drugs Product Overview
9.7.3 Abbott Gastrointestinal OTC Drugs Product Market Performance
9.7.4 Abbott Business Overview
9.7.5 Abbott Recent Developments
9.8 Sanofi
9.8.1 Sanofi Gastrointestinal OTC Drugs Basic Information
9.8.2 Sanofi Gastrointestinal OTC Drugs Product Overview
9.8.3 Sanofi Gastrointestinal OTC Drugs Product Market Performance
9.8.4 Sanofi Business Overview
9.8.5 Sanofi Recent Developments
9.9 Teva Pharmaceutical
9.9.1 Teva Pharmaceutical Gastrointestinal OTC Drugs Basic Information
9.9.2 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Overview
9.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Market Performance
9.9.4 Teva Pharmaceutical Business Overview
9.9.5 Teva Pharmaceutical Recent Developments
9.10 Nestle
9.10.1 Nestle Gastrointestinal OTC Drugs Basic Information
9.10.2 Nestle Gastrointestinal OTC Drugs Product Overview
9.10.3 Nestle Gastrointestinal OTC Drugs Product Market Performance
9.10.4 Nestle Business Overview
9.10.5 Nestle Recent Developments
9.11 Boehringer Ingelheim
9.11.1 Boehringer Ingelheim Gastrointestinal OTC Drugs Basic Information
9.11.2 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Overview
9.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Market Performance
9.11.4 Boehringer Ingelheim Business Overview
9.11.5 Boehringer Ingelheim Recent Developments
9.12 Reckitt Benckiser
9.12.1 Reckitt Benckiser Gastrointestinal OTC Drugs Basic Information
9.12.2 Reckitt Benckiser Gastrointestinal OTC Drugs Product Overview
9.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Product Market Performance
9.12.4 Reckitt Benckiser Business Overview
9.12.5 Reckitt Benckiser Recent Developments
9.13 Purdue Pharma
9.13.1 Purdue Pharma Gastrointestinal OTC Drugs Basic Information
9.13.2 Purdue Pharma Gastrointestinal OTC Drugs Product Overview
9.13.3 Purdue Pharma Gastrointestinal OTC Drugs Product Market Performance
9.13.4 Purdue Pharma Business Overview
9.13.5 Purdue Pharma Recent Developments
10 Gastrointestinal OTC Drugs Market Forecast by Region
10.1 Global Gastrointestinal OTC Drugs Market Size Forecast
10.2 Global Gastrointestinal OTC Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gastrointestinal OTC Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Gastrointestinal OTC Drugs Market Size Forecast by Region
10.2.4 South America Gastrointestinal OTC Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gastrointestinal OTC Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Gastrointestinal OTC Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gastrointestinal OTC Drugs by Type (2025-2030)
11.1.2 Global Gastrointestinal OTC Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gastrointestinal OTC Drugs by Type (2025-2030)
11.2 Global Gastrointestinal OTC Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Gastrointestinal OTC Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Gastrointestinal OTC Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gastrointestinal OTC Drugs Market Size Comparison by Region (M USD)
Table 5. Global Gastrointestinal OTC Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gastrointestinal OTC Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal OTC Drugs as of 2022)
Table 10. Global Market Gastrointestinal OTC Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gastrointestinal OTC Drugs Sales Sites and Area Served
Table 12. Manufacturers Gastrointestinal OTC Drugs Product Type
Table 13. Global Gastrointestinal OTC Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gastrointestinal OTC Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastrointestinal OTC Drugs Market Challenges
Table 22. Global Gastrointestinal OTC Drugs Sales by Type (Kilotons)
Table 23. Global Gastrointestinal OTC Drugs Market Size by Type (M USD)
Table 24. Global Gastrointestinal OTC Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Gastrointestinal OTC Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Gastrointestinal OTC Drugs Market Size Share by Type (2019-2024)
Table 28. Global Gastrointestinal OTC Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Gastrointestinal OTC Drugs Sales (Kilotons) by Application
Table 30. Global Gastrointestinal OTC Drugs Market Size by Application
Table 31. Global Gastrointestinal OTC Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Gastrointestinal OTC Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Gastrointestinal OTC Drugs Market Share by Application (2019-2024)
Table 35. Global Gastrointestinal OTC Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Gastrointestinal OTC Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Gastrointestinal OTC Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Gastrointestinal OTC Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Gastrointestinal OTC Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Gastrointestinal OTC Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. GlaxoSmithKline Gastrointestinal OTC Drugs Basic Information
Table 44. GlaxoSmithKline Gastrointestinal OTC Drugs Product Overview
Table 45. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GlaxoSmithKline Business Overview
Table 47. GlaxoSmithKline Gastrointestinal OTC Drugs SWOT Analysis
Table 48. GlaxoSmithKline Recent Developments
Table 49. Pfizer Gastrointestinal OTC Drugs Basic Information
Table 50. Pfizer Gastrointestinal OTC Drugs Product Overview
Table 51. Pfizer Gastrointestinal OTC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Pfizer Business Overview
Table 53. Pfizer Gastrointestinal OTC Drugs SWOT Analysis
Table 54. Pfizer Recent Developments
Table 55. Johnson and Johnson Gastrointestinal OTC Drugs Basic Information
Table 56. Johnson and Johnson Gastrointestinal OTC Drugs Product Overview
Table 57. Johnson and Johnson Gastrointestinal OTC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Johnson and Johnson Gastrointestinal OTC Drugs SWOT Analysis
Table 59. Johnson and Johnson Business Overview
Table 60. Johnson and Johnson Recent Developments
Table 61. Bayer Gastrointestinal OTC Drugs Basic Information
Table 62. Bayer Gastrointestinal OTC Drugs Product Overview
Table 63. Bayer Gastrointestinal OTC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Bayer Business Overview
Table 65. Bayer Recent Developments
Table 66. Procter and Gamble Gastrointestinal OTC Drugs Basic Information
Table 67. Procter and Gamble Gastrointestinal OTC Drugs Product Overview
Table 68. Procter and Gamble Gastrointestinal OTC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Procter and Gamble Business Overview
Table 70. Procter and Gamble Recent Developments
Table 71. Perrigo Gastrointestinal OTC Drugs Basic Information
Table 72. Perrigo Gastrointestinal OTC Drugs Product Overview
Table 73. Perrigo Gastrointestinal OTC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Perrigo Business Overview
Table 75. Perrigo Recent Developments
Table 76. Abbott Gastrointestinal OTC Drugs Basic Information
Table 77. Abbott Gastrointestinal OTC Drugs Product Overview
Table 78. Abbott Gastrointestinal OTC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Abbott Business Overview
Table 80. Abbott Recent Developments
Table 81. Sanofi Gastrointestinal OTC Drugs Basic Information
Table 82. Sanofi Gastrointestinal OTC Drugs Product Overview
Table 83. Sanofi Gastrointestinal OTC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Sanofi Business Overview
Table 85. Sanofi Recent Developments
Table 86. Teva Pharmaceutical Gastrointestinal OTC Drugs Basic Information
Table 87. Teva Pharmaceutical Gastrointestinal OTC Drugs Product Overview
Table 88. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Teva Pharmaceutical Business Overview
Table 90. Teva Pharmaceutical Recent Developments
Table 91. Nestle Gastrointestinal OTC Drugs Basic Information
Table 92. Nestle Gastrointestinal OTC Drugs Product Overview
Table 93. Nestle Gastrointestinal OTC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Nestle Business Overview
Table 95. Nestle Recent Developments
Table 96. Boehringer Ingelheim Gastrointestinal OTC Drugs Basic Information
Table 97. Boehringer Ingelheim Gastrointestinal OTC Drugs Product Overview
Table 98. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Boehringer Ingelheim Business Overview
Table 100. Boehringer Ingelheim Recent Developments
Table 101. Reckitt Benckiser Gastrointestinal OTC Drugs Basic Information
Table 102. Reckitt Benckiser Gastrointestinal OTC Drugs Product Overview
Table 103. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Reckitt Benckiser Business Overview
Table 105. Reckitt Benckiser Recent Developments
Table 106. Purdue Pharma Gastrointestinal OTC Drugs Basic Information
Table 107. Purdue Pharma Gastrointestinal OTC Drugs Product Overview
Table 108. Purdue Pharma Gastrointestinal OTC Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Purdue Pharma Business Overview
Table 110. Purdue Pharma Recent Developments
Table 111. Global Gastrointestinal OTC Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Gastrointestinal OTC Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Gastrointestinal OTC Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Gastrointestinal OTC Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Gastrointestinal OTC Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Gastrointestinal OTC Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Gastrointestinal OTC Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Gastrointestinal OTC Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Gastrointestinal OTC Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Gastrointestinal OTC Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Gastrointestinal OTC Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Gastrointestinal OTC Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Gastrointestinal OTC Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Gastrointestinal OTC Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Gastrointestinal OTC Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Gastrointestinal OTC Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Gastrointestinal OTC Drugs Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Gastrointestinal OTC Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal OTC Drugs Market Size (M USD), 2019-2030
Figure 5. Global Gastrointestinal OTC Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Gastrointestinal OTC Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal OTC Drugs Market Size by Country (M USD)
Figure 11. Gastrointestinal OTC Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers in 2023
Figure 13. Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gastrointestinal OTC Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal OTC Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gastrointestinal OTC Drugs Market Share by Type
Figure 18. Sales Market Share of Gastrointestinal OTC Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Gastrointestinal OTC Drugs by Type in 2023
Figure 20. Market Size Share of Gastrointestinal OTC Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Gastrointestinal OTC Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gastrointestinal OTC Drugs Market Share by Application
Figure 24. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Gastrointestinal OTC Drugs Sales Market Share by Application in 2023
Figure 26. Global Gastrointestinal OTC Drugs Market Share by Application (2019-2024)
Figure 27. Global Gastrointestinal OTC Drugs Market Share by Application in 2023
Figure 28. Global Gastrointestinal OTC Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Gastrointestinal OTC Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Gastrointestinal OTC Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Gastrointestinal OTC Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Gastrointestinal OTC Drugs Sales Market Share by Country in 2023
Figure 37. Germany Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Gastrointestinal OTC Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Region in 2023
Figure 44. China Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Gastrointestinal OTC Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Gastrointestinal OTC Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Gastrointestinal OTC Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Gastrointestinal OTC Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Gastrointestinal OTC Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gastrointestinal OTC Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gastrointestinal OTC Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Gastrointestinal OTC Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Gastrointestinal OTC Drugs Market Share Forecast by Application (2025-2030)
